Doxycycline administration improves fascial interface in hernia repair

Area of Science:

• Biomedical Engineering
• Tissue Engineering
• Surgical Innovation

Background:

• Ventral hernia repair recurrence rates remain high, linked to matrix metalloproteinases (MMPs) and altered collagen ratios.
• Previous studies showed doxycycline reduced MMPs and improved collagen ratios, but tensile strength increase was not significant.
• This study investigated if extended doxycycline treatment duration enhances repaired fascial tissue strength.

Purpose of the Study:

• To evaluate the impact of extended doxycycline administration on the tensile strength of mesh-to-fascia interface (MFI) tissue after ventral hernia repair.
• To assess the effects of prolonged doxycycline treatment on MMP levels and collagen subtype ratios in repaired tissues.
• To determine if extended treatment duration improves the biomechanical integrity of the repaired hernia site.

Main Methods:

• Thirty-two rats underwent polypropylene mesh repair for incisional hernias.
• Animals received saline or doxycycline from 1 day pre-repair until 6 or 12 weeks post-repair.
• Tissue samples were analyzed for MMPs and collagen subtypes via Western blot, with tensiometric analysis performed.

Main Results:

• Doxycycline treatment significantly increased MFI tensiometric strength at both 6 and 12 weeks compared to controls.
• Collagen-1, -2, and -3 ratios were markedly increased in doxycycline-treated MFI at both time points.
• Doxycycline modulated MMP levels, with significant decreases in MMP-2 and MMP-9 observed at specific time points.

Conclusions:

• Extended doxycycline administration significantly enhances the tensile strength of repaired fascial interface tissue.
• Doxycycline treatment leads to a remarkable increase in collagen-1, -2, and -3 ratios in the repaired tissue.
• This study suggests doxycycline is a promising therapeutic agent for improving outcomes in ventral hernia repair.